¼¼°èÀÇ ÀÇ·á±â±â ½ÃÇè ½ÃÀå
Medical Device Testing
»óǰÄÚµå : 1655351
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 182 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ÀÇ·á±â±â ½ÃÇè ½ÃÀåÀº 2030³â±îÁö 176¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 133¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ÀÇ·á±â±â ½ÃÇè ½ÃÀåÀº 2024-2030³â¿¡ CAGR 4.8%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 176¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ Å×½ºÆ® ¼­ºñ½º´Â CAGR 5.5%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 76¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °Ë»ç ¼­ºñ½º ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ÀÇ CAGR·Î 4.9%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 37¾ï ´Þ·¯, Áß±¹Àº CAGR 4.5%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÀÇ·á±â±â ½ÃÇè ½ÃÀåÀº 2024³â¿¡ 37¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 28¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 4.5%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 4.5%¿Í 4.0%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è ÀÇ·á±â±â ½ÃÇè½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

ÀÇ·á±â±â ½ÃÇèÀ̶õ ¹«¾ùÀ̸ç, ¿Ö ÇコÄɾ Áß¿äÇѰ¡?

ÀÇ·á±â±â ½ÃÇèÀº ÁÖ»ç±âó·³ °£´ÜÇÑ °ÍºÎÅÍ ·Îº¿ ¼ö¼ú ½Ã½ºÅÛó·³ º¹ÀâÇÑ °Í±îÁö ¸ðµç À¯ÇüÀÇ ÀÇ·á±â±â°¡ ½ÃÀå¿¡ Ãâ½ÃµÇ±â Àü¿¡ ¾ö°ÝÇÑ ¾ÈÀü¼º ¹× À¯È¿¼º ±âÁØÀ» ÃæÁ·ÇÏ´ÂÁö È®ÀÎÇϱâ À§ÇØ ¾ö°ÝÇÑ Æò°¡¸¦ °ÅÃÄ¾ß ÇÏ´Â Áß¿äÇÑ °úÁ¤ÀÔ´Ï´Ù. ÀÌ °úÁ¤Àº Àü ¼¼°è ±ÔÁ¦ ¿ä°ÇÀ» ÁؼöÇÏ´Â °Í»Ó¸¸ ¾Æ´Ï¶ó ½É°¢ÇÑ °Ç°­ À§Çè°ú »ç¸Á »ç°í·Î À̾îÁú ¼ö ÀÖ´Â ±â±â ¿ÀÀÛµ¿À» ¹æÁöÇÏ´Â µ¥¿¡µµ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÇ·á ±â¼úÀÌ ¹ßÀüÇÏ°í ´õ Á¤±³ÇÑ ÀüÀÚ ¹× ±â°è ºÎǰÀÌ ÅëÇյʿ¡ µû¶ó ¼ÒÇÁÆ®¿þ¾î °ËÁõ, »çÀ̹ö º¸¾È Æò°¡, »ýü ÀûÇÕ¼º Å×½ºÆ® µî Å×½ºÆ®ÀÇ ¹üÀ§°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ã¶ÀúÇÑ Å×½ºÆ®´Â ¹Ì±¹ FDA, À¯·´ EMA ¹× ±âŸ ±¹Á¦±â±¸¿Í °°Àº ±ÔÁ¦±â°ü¿¡¼­ ÀÇ·á±â±â°¡ ´Ù¾çÇÑ Á¶°Ç¿¡¼­ ÀǵµµÈ ¼ö¸í µ¿¾È ¾ÈÀüÇϰí È¿°úÀûÀ¸·Î ÀÛµ¿ÇÒ ¼ö ÀÖµµ·Ï Çϱâ À§ÇØ Àǹ«È­µÇ¾î ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ Áúº´À» Áø´Ü, ¿¹¹æ, Ä¡·á ¹× °ü¸®ÇÏ´Â µ¥ ÀÖÀ¸¸ç, ÀÇ·á±â±â´Â ¸Å¿ì Áß¿äÇϹǷΠÁ¾ÇÕÀûÀÎ Å×½ºÆ®´Â ÀÇ·á±â±âÀÇ ¼ö¸íÁֱ⿡¼­ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

±â¼ú Çõ½ÅÀº ÀÇ·á±â±â ½ÃÇèÀ» ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?

±â¼ú Çõ½ÅÀº ÀÇ·á±â±â ½ÃÇè¿¡ ±ØÀûÀÎ º¯È­¸¦ °¡Á®¿ÔÀ¸¸ç, º¸´Ù Á¤±³ÇÑ ¹æ¹ý°ú ÅøÀ» µµÀÔÇÏ¿© ½ÃÇè °úÁ¤ÀÇ È¿À²¼º°ú Æ÷°ý¼ºÀ» Çâ»ó½ÃÄ×½À´Ï´Ù. µðÁöÅÐ ½Ã¹Ä·¹À̼ǰú °è»ê ¸ðµ¨¸µÀº ¼ö¸¹Àº »ý¸®Àû Á¶°Ç¿¡¼­ ±â±âÀÇ °Åµ¿À» ¿¹ÃøÇÏ´Â µ¥ ¸Å¿ì À¯¿ëÇÏ°Ô »ç¿ëµÇ¾î Ãʱ⠴ܰèÀÇ ÀÓ»ó½ÃÇè°ú µ¿¹° ½ÇÇè¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³·Ãß°í ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ °³¹ß ÇÁ·Î¼¼½ºÀÇ ¼Óµµ¸¦ ³ôÀÏ »Ó¸¸ ¾Æ´Ï¶ó ºñ¿ëµµ Å©°Ô Àý°¨ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ºÐ¾ß¿¡¼­ ¿þ¾î·¯ºí ±â¼ú°ú IoT°¡ ºÎ»óÇÔ¿¡ µû¶ó ¿¬°á¼º°ú ¿¬¼Ó ÀÛµ¿¿¡ ´ëÇÑ »õ·Î¿î µµÀü°ú ¿ä±¸»çÇ×ÀÌ »ý°Ü³µÀ¸¸ç, ½ÇÁ¦ ȯ°æ¿¡¼­ ½Å·ÚÇÒ ¼ö ÀÖ´Â ¼º´ÉÀ» º¸ÀåÇϱâ À§ÇØ ±¤¹üÀ§ÇÑ ³»±¸¼º Å×½ºÆ®¿Í ±â´É Å×½ºÆ®°¡ ÇÊ¿äÇÕ´Ï´Ù. ¶ÇÇÑ ÀÇ·á±â±â¿¡ ÀΰøÁö´É°ú ¸Ó½Å·¯´×ÀÇ ÅëÇÕÀº °³ÀÎÈ­µÈ ÀÇ·á ¹× ¿¹Ãø ºÐ¼® Ãø¸é¿¡¼­ Àü·Ê ¾ø´Â ±â´ÉÀ» Á¦°øÇÏ´Â ÇÑÆí, ÀÌ·¯ÇÑ ±â±âÀÇ ÆÇ´ÜÀÌ Á¤È®ÇÏ°í ¾ÈÀüÇÏ´Ù´Â °ÍÀ» º¸ÀåÇϱâ À§ÇØ ¾ö°ÝÇÑ ¾Ë°í¸®Áò °ËÁõÀ» ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀº ÃֽŠÀÇ·á±â±âÀÇ º¹À⼺¿¡ È¿°úÀûÀ¸·Î ´ëÀÀÇϱâ À§ÇØ Å×½ºÆ® ÇÁ·ÎÅäÄݰú Ç¥ÁØÀÇ º´ÇàÀûÀÎ ÁøÈ­¸¦ ÇÊ¿ä·Î ÇÕ´Ï´Ù.

ÀÇ·á±â±â ½ÃÇè ½Ç¹«¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ±ÔÁ¦ º¯È­´Â ¹«¾ùÀΰ¡?

ÀÇ·á±â±â ºÐ¾ß´Â ±ÔÁ¦°¡ ¾ö°ÝÇϰí, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©ÀÇ º¯È­´Â Á¾Á¾ ½ÃÇè ¼öÇà¿¡ Å« ¿µÇâÀ» ¹ÌĨ´Ï´Ù. Ãֱ٠ǥÁØ ¹× °¡À̵å¶óÀÎÀÇ ¾÷µ¥ÀÌÆ®´Â ÀÇ·á±â±â¿¡ ¿ä±¸µÇ´Â ÀÓ»ó °ËÁõ ¹× À§Çè Æò°¡ÀÇ ¾ö°Ý¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. À¯·´¿¬ÇÕÀÇ ÀÇ·á±â±â ±ÔÁ¤(MDR)ÀÇ ½ÃÇà°ú FDAÀÇ ½ÂÀÎ ÇÁ·Î¼¼½º º¯°æÀº º¸´Ù ¾ö°ÝÇÑ Å×½ºÆ®¿Í ¹®¼­È­¸¦ ¿ä±¸ÇÏ´Â ±ÔÁ¦ º¯È­ÀÇ ÇÑ ¿¹ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ º¯È­´Â ȯÀÚÀÇ ¾ÈÀüÀ» ³ôÀÌ°í ½ÃÀå¿¡ Ãâ½ÃµÇ´Â ÀÇ·á±â±âÀÇ Àü¹ÝÀûÀΠǰÁúÀ» Çâ»ó½ÃŰ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. Á¦Á¶¾÷üÀÇ °æ¿ì, ±ÔÁ¤ Áؼö¸¦ À¯ÁöÇϱâ À§Çؼ­´Â Ãʱ⠽ÃÇè»Ó¸¸ ¾Æ´Ï¶ó Áö¼ÓÀûÀÎ ½ÃÆÇ ÈÄ Á¶»ç¸¦ ÅëÇØ ±â±âÀÇ ¼º´ÉÀ» ¸ð´ÏÅ͸µÇϰí Áö¼ÓÀûÀÎ ±ÔÁ¤ Áؼö¸¦ º¸ÀåÇØ¾ß ÇÕ´Ï´Ù. ±ÔÁ¦ ¿ä°ÇÀÇ ¿ªµ¿ÀûÀΠƯ¼ºÀ¸·Î ÀÎÇØ ±â¾÷Àº Å×½ºÆ® ÇÁ·Î¼¼½ºÀÇ À¯¿¬¼ºÀ» À¯ÁöÇϰí ÄÄÇöóÀ̾𽺠Àü·«À» ÀûÀýÈ÷ Áغñ ¹× Á¶Á¤Çϱâ À§ÇØ ÃֽŠº¯°æ »çÇ×À» Áö¼ÓÀûÀ¸·Î ÆÄ¾ÇÇØ¾ß ÇÕ´Ï´Ù.

ÀÇ·á±â±â Å×½ºÆ® ½ÃÀåÀÇ ¼ºÀåÀº ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁý´Ï´Ù.

ÀÇ·á±â±â Å×½ºÆ® ½ÃÀåÀÇ ¼ºÀåÀº ÀÇ·á ¹× ±ÔÁ¦ ȯ°æÀÇ ¿ªµ¿¼ºÀ» ¹Ý¿µÇÏ´Â ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀ» ¸ð´ÏÅ͸µÇϰí Ä¡·áÇÏ´Â ¿þ¾î·¯ºí ±â±â, À̽ÄÇü ±â±â µî ÷´Ü ±â±âÀÇ °³¹ßÀÌ ±ÞÁõÇϸ鼭 º¹ÀâÇÑ ÀüÀÚ±â±â¿Í µ¥ÀÌÅÍ °ü¸® ½Ã½ºÅÛÀ» ´Ù·ê ¼ö ÀÖ´Â º¸´Ù Àü¹®ÀûÀÎ °Ë»ç ¼­ºñ½º¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Àü ¼¼°è¿¡¼­ °Ç°­¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í °í·ÉÈ­°¡ ÁøÇàµÊ¿¡ µû¶ó Çõ½ÅÀûÀÎ ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó ÀÌ·¯ÇÑ ±â¼úÀÌ ¾ÈÀüÇϰí È¿°úÀûÀÎÁö È®ÀÎÇϱâ À§ÇÑ ½ÃÇèÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á±â±â ½ÃÀåÀÌ ½ÅÈï ±¹°¡À¸·Î È®´ëµÊ¿¡ µû¶ó »õ·Î¿î ±ÔÁ¦ °úÁ¦¿Í ÄÄÇöóÀ̾𽺠¿ä±¸»çÇ×ÀÌ µµÀÔµÇ¾î ´Ù¾çÇÑ ±ÔÁ¦ ȯ°æ¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â ÇöÁö ½ÃÇè ½Ã¼³¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î ½ÃÇè Àåºñ¿Í ½ÃÇè ¹æ¹ýÀÇ ±â¼úÀû ¹ßÀüÀ¸·Î º¸´Ù ½Å¼ÓÇϰí Á¤È®ÇÑ Æò°¡°¡ °¡´ÉÇØÁö¸é¼­ öÀúÇϰí È¿À²ÀûÀÎ ÀÇ·á±â±â ½ÃÇè ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© Àü ¼¼°è ÀÇ·á±â¼úÀÇ ¾ÈÀü°ú ±â´É¼ºÀ» º¸ÀåÇÏ´Â µ¥ ÀÖÀ¸¸ç, ÀÇ·á±â±â Å×½ºÆ® ½ÃÀåÀÇ °ß°íÇÑ ¼ºÀå°ú Á߿伺À» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

¼­ºñ½º(½ÃÇè, °Ë»ç, ÀÎÁõ, ±âŸ ¼­ºñ½º);&±â¼ú(ü¿ÜÁø´Ü¿ë ÀÇ·á±â±â, ´Éµ¿Çü ÀÇ·á±â±â, ¾È°ú¿ë ÀÇ·á±â±â, ´Éµ¿Çü ÀÓÇöõÆ® ÀÇ·á±â±â, ºñ´Éµ¿Çü ÀÇ·á±â±â, Ç÷°ü¿ë ÀÇ·á±â±â, Á¤Çü¿Ü°ú-Ä¡°ú¿ë ÀÇ·á±â±â, ±âŸ ±â¼ú)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÃÑ 17°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Medical Device Testing Market to Reach US$17.6 Billion by 2030

The global market for Medical Device Testing estimated at US$13.3 Billion in the year 2024, is expected to reach US$17.6 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Testing Service, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$7.6 Billion by the end of the analysis period. Growth in the Inspection Service segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.7 Billion While China is Forecast to Grow at 4.5% CAGR

The Medical Device Testing market in the U.S. is estimated at US$3.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 4.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Medical Device Testing Market - Key Trends & Drivers Summarized

What Is Medical Device Testing and Why Is It Paramount to Healthcare?

Medical device testing is an essential process that involves rigorous evaluation to ensure that all types of medical devices, whether they are as simple as a syringe or as complex as a robotic surgical system, meet stringent safety and efficacy standards before they are introduced to the market. This process is crucial not only to comply with global regulatory requirements but also to prevent device malfunctions that could result in serious health risks or fatalities. As medical technology evolves, incorporating more sophisticated electronic and mechanical components, the scope of testing expands to include software validation, cybersecurity assessments, and biocompatibility studies. This thorough testing is mandated by regulatory authorities such as the FDA in the U.S., the EMA in Europe, and other international bodies to ensure that the medical devices perform safely and effectively under varied conditions and throughout their intended lifespan. The critical nature of these devices in diagnosing, preventing, treating, and managing a variety of medical conditions makes their comprehensive testing a non-negotiable aspect of the medical device lifecycle.

How Are Innovations in Technology Transforming Medical Device Testing?

Innovation in technology has dramatically transformed medical device testing, introducing more sophisticated methods and tools that enhance both the efficiency and comprehensiveness of the testing process. Digital simulations and computational modeling have become invaluable in predicting device behavior under a myriad of physiological conditions, reducing the reliance on early-stage clinical trials and animal testing. This not only speeds up the development process but also reduces costs significantly. The rise of wearable technology and IoT in healthcare has introduced new challenges and requirements for connectivity and continuous operation, necessitating extensive durability and functional tests to ensure reliable performance in real-world settings. Moreover, the integration of artificial intelligence and machine learning in medical devices, while offering unprecedented capabilities in terms of personalized medicine and predictive analytics, also demands rigorous algorithm validation to ensure decisions made by these devices are accurate and safe. These technological advancements require a parallel evolution in testing protocols and standards to effectively address the complexities of modern medical devices.

What Regulatory Changes Impact Medical Device Testing Practices?

The medical device sector is heavily regulated, and changes in regulatory frameworks often have a profound impact on testing practices. Recent updates in standards and guidelines have increased the rigor of clinical validation and risk assessment required for medical devices. The implementation of the European Union's Medical Device Regulation (MDR) and changes to the FDA's approval processes are examples of regulatory evolutions that demand more stringent testing and documentation. These changes aim to enhance patient safety and improve the overall quality of medical devices on the market. For manufacturers, staying compliant involves not just initial testing but continuous post-market surveillance to monitor device performance and ensure ongoing compliance. The dynamic nature of regulatory requirements compels companies to maintain flexibility in their testing processes and to stay informed of the latest changes to adequately prepare and adjust their compliance strategies.

Growth in the Medical Device Testing Market Is Driven by Several Factors

The growth in the medical device testing market is driven by several factors that reflect the evolving dynamics within the healthcare and regulatory landscapes. The surge in development of high-tech devices such as wearables and implantables that monitor and treat chronic conditions has created a need for more specialized testing services that can handle complex electronics and data management systems. Increasing global health concerns and an aging population have intensified the demand for innovative medical solutions, subsequently increasing the need for testing to ensure these technologies are safe and effective. Furthermore, the expansion of medical device markets into emerging economies has introduced additional regulatory challenges and compliance requirements, boosting the demand for local testing facilities that can navigate diverse regulatory environments. Lastly, technological advancements in testing equipment and methodologies are enabling faster, more accurate assessments, making it feasible to meet the growing demand for thorough and efficient device testing services. These factors together underscore the robust expansion and the critical importance of the medical device testing market in ensuring the safety and functionality of medical technologies worldwide.

SCOPE OF STUDY:

The report analyzes the Medical Device Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service (Testing, Inspection, Certification, Other Services); Technology (In-Vitro Diagnostic Medical Devices, Active Medical Devices, Ophthalmic Medical Devices, Active Implant Medical Devices, Non-Active Medical Devices, Vascular Medical Devices, Orthopedic & Dental Medical Devices, Other Technologies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 17 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â